Roche gets breakthrough status for Alzheimer's test Elecsys

The U.S. Food and Drug Administration has granted Roche an accelerated review for its Elecsys product used to diagnose Alzheimer's disease, the Swiss drugmaker said on Friday.

from Reuters: Health News https://ift.tt/2L8g1UV